| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 08/05/2024 | 23:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ANIK | Anika Therapeutics Inc |
| 08/05/2024 | 22:12 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ANIK | Anika Therapeutics Inc |
| 08/05/2024 | 22:08 | GlobeNewswire Inc. | Anika Announces CFO Transition | NASDAQ:ANIK | Anika Therapeutics Inc |
| 08/05/2024 | 22:05 | GlobeNewswire Inc. | Anika Reports First Quarter 2024 Financial Results | NASDAQ:ANIK | Anika Therapeutics Inc |
| 03/05/2024 | 22:01 | GlobeNewswire Inc. | Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:ANIK | Anika Therapeutics Inc |
| 18/04/2024 | 22:01 | GlobeNewswire Inc. | Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024 | NASDAQ:ANIK | Anika Therapeutics Inc |
| 02/04/2024 | 14:00 | GlobeNewswire Inc. | Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference | NASDAQ:ANIK | Anika Therapeutics Inc |
| 13/03/2024 | 21:05 | GlobeNewswire Inc. | Anika Reports Fourth Quarter and Year-End 2023 Financial Results | NASDAQ:ANIK | Anika Therapeutics Inc |
| 13/03/2024 | 12:03 | IH Market News | Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb | NASDAQ:ANIK | Anika Therapeutics Inc |
| 07/03/2024 | 01:30 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:ANIK | Anika Therapeutics Inc |
| 27/02/2024 | 22:01 | GlobeNewswire Inc. | Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024 | NASDAQ:ANIK | Anika Therapeutics Inc |
| 13/02/2024 | 15:00 | GlobeNewswire Inc. | Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting | NASDAQ:ANIK | Anika Therapeutics Inc |
| 09/02/2024 | 17:09 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:ANIK | Anika Therapeutics Inc |
| 22/01/2024 | 15:29 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:ANIK | Anika Therapeutics Inc |
| 19/01/2024 | 22:52 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:ANIK | Anika Therapeutics Inc |
| 12/01/2024 | 22:35 | Edgar (US Regulatory) | Form 3/A - Initial statement of beneficial ownership of securities: [Amend] | NASDAQ:ANIK | Anika Therapeutics Inc |
| 28/11/2023 | 15:00 | GlobeNewswire Inc. | Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release | NASDAQ:ANIK | Anika Therapeutics Inc |
| 07/11/2023 | 22:05 | GlobeNewswire Inc. | Anika to Participate in Upcoming Investor Conferences | NASDAQ:ANIK | Anika Therapeutics Inc |
| 02/11/2023 | 21:05 | GlobeNewswire Inc. | Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business | NASDAQ:ANIK | Anika Therapeutics Inc |
| 10/10/2023 | 15:00 | GlobeNewswire Inc. | Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023 | NASDAQ:ANIK | Anika Therapeutics Inc |
| 03/10/2023 | 22:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ANIK | Anika Therapeutics Inc |
| 19/09/2023 | 15:00 | GlobeNewswire Inc. | Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting | NASDAQ:ANIK | Anika Therapeutics Inc |
| 12/09/2023 | 15:00 | GlobeNewswire Inc. | Anika to Participate in the Sidoti Small Cap Virtual Investor Conference | NASDAQ:ANIK | Anika Therapeutics Inc |
| 02/09/2023 | 00:51 | PR Newswire (US) | Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 | NASDAQ:ANIK | Anika Therapeutics Inc |
| 18/08/2023 | 01:57 | Dow Jones News | Anika Rotator-Cuff Treatment May Launch in 1Q Following Final FDA Approval | NASDAQ:ANIK | Anika Therapeutics Inc |
| 18/08/2023 | 00:20 | GlobeNewswire Inc. | Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs | NASDAQ:ANIK | Anika Therapeutics Inc |
| 17/08/2023 | 14:00 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial ownership | NASDAQ:ANIK | Anika Therapeutics Inc |
| 08/08/2023 | 22:05 | GlobeNewswire Inc. | Anika Reports Second Quarter 2023 Financial Results | NASDAQ:ANIK | Anika Therapeutics Inc |
| 20/07/2023 | 22:05 | GlobeNewswire Inc. | Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023 | NASDAQ:ANIK | Anika Therapeutics Inc |
| 12/07/2023 | 15:00 | GlobeNewswire Inc. | Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting | NASDAQ:ANIK | Anika Therapeutics Inc |